Pharmaceutical Business review

FDA issues alert on lack of sterility assurance of ApotheCure, NuVision drugs

The warning was based on ongoing inspection that raised lack of sterility assurance concerns in the facilities related to both the companies.

A voluntarily recall of all sterile products made and distributed by ApotheCure and all sterile lyophilized products made and distributed by NuVision is commenced by the respective companies.